Alibaba to pay US $600M to settle allegations it allowed illegal drug and equipment sales

WASHINGTON (AP) — The Chinese tech giant Alibaba will pay $600 million to resolve a dispute with the U.S. government over allegations that the Hangzhou-based firm sold and imported illegal pharmaceuticals, controlled substances, regulated chemicals, and pill-making equipment into the U.S. Alibaba o...

Redirecting to full article...